Search

Your search keyword '"Tesař, Vladimír"' showing total 470 results

Search Constraints

Start Over You searched for: Author "Tesař, Vladimír" Remove constraint Author: "Tesař, Vladimír"
470 results on '"Tesař, Vladimír"'

Search Results

1. Data-driven subclassification of ANCA-associated vasculitis: model-based clustering of a federated international cohort

2. Long-Term Results from an Open-Label Extension Study of Atacicept for the Treatment of IgA Nephropathy

7. An update on the global disparities in kidney disease burden and care across world countries and regions

12. Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

16. The impact of treatment with avacopan on health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis: a post-hoc analysis of data from the ADVOCATE trial

18. Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial

19. Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy

20. Addition of Endothelin A-Receptor Blockade Spoils the Beneficial Effect of Combined Renin-Angiotensin and Soluble Epoxide Hydrolase Inhibition: Studies on the Course of Chronic Kidney Disease in 5/6 Nephrectomized Ren-2 Transgenic Hypertensive Rats

21. Early Identification of CKD—A Scoping Review of the Global Populations

23. Incidence of Kidney Replacement Therapy and Subsequent Outcomes Among Patients With Systemic Lupus Erythematosus: Findings From the ERA Registry

24. Nephrology in the Czech Republic

26. Combined Inhibition of Soluble Epoxide Hydrolase and Renin-Angiotensin System Exhibits Superior Renoprotection to Renin-Angiotensin System Blockade in 5/6 Nephrectomized Ren-2 Transgenic Hypertensive Rats with Established Chronic Kidney Disease

27. WCN24-1674 NEFECON TREATMENT RESPONSE IN ASIAN AND WHITE PATIENT POPULATIONS WITH IMMUNOGLOBULIN A NEPHROPATHY: A 2YEAR ANALYSIS OF THE PHASE III NEFIGARD TRIAL

28. WCN24-1774 eGFR DECLINE IN PATIENTS WITH IgAN TREATED WITH NEFECON OR PLACEBO: RESULTS FROM THE 2-YEAR NefIgArd PHASE 3 TRIAL

29. WCN24-1776 NEFECON EFFECT ON QUALITY OF LIFE IN PATIENTS WITH IgAN: SF-36 RESULTS FROM THE PHASE 3 NeFIgArd TRIAL

30. WCN24-1777 NEFECON TREATMENT PROVIDES KIDNEY BENEFITS FOR PATIENTS WITH IgAN THAT EXTEND TO THOSE WITH LOW LEVELS OF UPCR: A SUB-ANALYSIS OF THE PHASE III NefIgArd TRIAL

31. Chronic kidney disease and pregnancy outcomes

32. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases

33. Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases

35. Development and testing of an artificial intelligence tool for predicting end-stage kidney disease in patients with immunoglobulin A nephropathy

36. Rituximab in Membranous Nephropathy

37. Peritoneal Dialysis Use and Practice Patterns: An International Survey Study

38. Hemodialysis Use and Practice Patterns: An International Survey Study

39. HLA-D and PLA2R1 risk alleles associate with recurrent primary membranous nephropathy in kidney transplant recipients

41. KDIGO Controversies Conference on onco-nephrology: kidney disease in hematological malignancies and the burden of cancer after kidney transplantation

42. Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?

43. Considerations on equity in management of end-stage kidney disease in low- and middle-income countries

45. Elimination and penetration of Amikacin into urine in patients with decreased glomerular filtration rate

46. Status of care for end stage kidney disease in countries and regions worldwide : international cross sectional survey

48. Outcomes from the International Society of Nephrology Hemolytic Uremic Syndromes International Forum

Catalog

Books, media, physical & digital resources